Qualaquin
Links shared publicly online about this topic
Unapproved Qualaquin Use Is Risky
webmd.com — “The FDA has issued a new warning about the use of the malaria drug Qualaquin (quinine sulfate) to prevent or treat nighttime leg cramps, stating that it can cause serious side effects.” View full resource at webmd.com
Most Recently Shared on July 13, 2010 at 9:29 pm By:
webMD: Unapproved Qualaquin Use Is Risky http://bit.ly/ar3kuK Full http://bit.ly/dufSdW
FDA Warns of Risks with Unapproved Use of Malaria Drug Qualaquin
fda.gov — “The U.S. Food and Drug Administration today warned that the unapproved use of the malaria drug Qualaquin (quinine sulfate) to treat night time leg cramps has resulted in serious side effects and prompted the manufacturer to develop a risk management plan aimed at educating health care professionals and patients about the potential risks.” View full resource at fda.gov
Most Recently Shared on July 12, 2010 at 4:49 pm By:
Infusion Nurse Nurse and Advanced Practice Nurse
FDA Warns of Risks with Unapproved Use of Malaria Drug Qualaquin: http://bit.ly/cbhs79 via @addthis
FDA approves Risk Evaluation and Mitigation Strategy (REMS) for Qualaquin - ONA
oncologynurseadvisor.com — “The FDA has approved a Risk Evaluation and Mitigation Strategy (REMS) for Qualaquin (quinine sulfate capsules, from AR Scientific) to warn against --off-label-- uses.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 9, 2010 at 2:25 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA approves Risk Evaluation and Mitigation Strategy (REMS) for Qualaquin http://goo.gl/fb/QeJUc
Important Drug Alert: Qualaquin - Related Stories - AAP SmartBrief
smartbrief.com — “An important FDA-approved Drug Alert for Qualaquin affecting many specialties, including pediatric orthopedics, was published on Aug. 16. This PDR® Drug Alert (HCNN) was delivered electronically to all American Academy of Pediatrics members registered with PDR® Network. If you ha…” View full resource at smartbrief.com
Most Recently Shared on August 24, 2011 at 3:59 pm By:
Clara Song Pediatrician, Physician, and Doctor
Important Drug Alert: Qualaquin http://t.co/PL61DG2
FDA approves Risk Evaluation and Mitigation Strategy (REMS) for Qualaquin - MPR
empr.com — “The FDA has approved a Risk Evaluation and Mitigation Strategy (REMS) for Qualaquin (quinine sulfate capsules, from AR Scientific) to warn against off-label uses.” View full resource at empr.com
Most Recently Shared on July 9, 2010 at 2:05 pm By:
MPR News: FDA approves Risk Evaluation and Mitigation Strategy (REMS) for Qualaquin: The FDA has approved a Risk E... http://bit.ly/blLLdv
FDA Alert: Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy - Risk of serious hematological reactions
drugs.com — “FDA Alert: Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy - Risk of serious hematological reactions” View full resource at drugs.com
Most Recently Shared on July 8, 2010 at 8:05 pm By:
FDA Alert - FDA Warns Against "Off-Label" Use of Qualaquin - http://bit.ly/aBUoPD
Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy - Risk of serious hematological reactions
fda.gov — “New Risk Management Plan. Reports of serious side effects in patients using Qualaquin” View full resource at fda.gov
Most Recently Shared on July 10, 2010 at 4:29 am By:
The Kidney Group Physician Group and Nephrology
FDA warns against quinine for leg cramps.http://tinyurl.com/2dnsv9z
Using Malaria Medication for Leg Cramps is Risky
drugs.com — “Using Malaria Medication for Leg Cramps is Risky” View full resource at drugs.com
Most Recently Shared on July 8, 2010 at 11:55 pm By:
Using Malaria Medication for Leg Cramps is Risky - http://bit.ly/bQIWPI
News Briefs: Week of Aug. 9-13 -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “This roundup includes the following news briefs: Marketer Adds Boxed Warning to Qualaquin; Appeals Court Upholds Law Restricting Access to Physician Prescription Information; Merck Updates Foradil Prescribing Information; Family Physicians Most Satisfied in Medical School Workplace, Study Says; HHS Releases $250 Million in New Grant Funds for Community Health Centers; Illinois Taps Knowledge, Expertise of Family Physicians For Insurance Review Process; Sanofi Pasteur Shortening Shelf Life of 200” View full resource at aafp.org
Most Recently Shared on August 12, 2010 at 4:46 am By:
News Briefs: Week of Aug. 9-13: This roundup includes the following news briefs: Marketer Adds Boxed Warning to Qu... http://bit.ly/b8QvBJ
Medical News: FDA Warns Against Malaria Drug Use for RLS - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA warned consumers against using the malaria drug quinine sulfate (Qualaquin) for treatment of nightly leg cramps and restless legs syndrome (RLS) due to the potentially fatal side” View full resource at medpagetoday.com
Most Recently Shared on July 8, 2010 at 8:55 pm By:
FDA warns against malaria drug use in restless legs syndrome: http://bit.ly/9donLU
FDA Warns Against Using Malaria Drug for Leg Cramps - WSJ.com
online.wsj.com — “The FDA warned patients and doctors against using a malaria drug to treat or prevent leg cramps because of the risk of serious blood disorders.” View full resource at online.wsj.com
Most Recently Shared on July 8, 2010 at 10:30 pm By:
Hisham Rana, MD Doctor and Physician
News: FDA warns against using malaria drug Qualaquin (quinine) for leg cramps after adverse reactions & deaths http://bit.ly/dg0OJO #health
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
-
Infusion Nurse
Ask me anything you want to know about Vascular Access and Infusion Therapy. Read my blog http://infusionnurse.org
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Advertisement
